Conditions: Type 1 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 171
Healthy volunteers: no

Brief summary:
To obtain safety and tolerability information in patients with type 1 diabetes where Dapagliflozin is added on to Insulin (for 14 days)

Detailed description:
Study Classification : Safety, Pharmacokinetics and Pharmacodynamics

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None

Interventions: intervention 1: Dapagliflozin intervention 2: Placebo matching Dapagliflozin
Intervention descriptions: intervention 1: Tablets, Oral, 1 mg, Once daily, 14 days intervention 2: Tablets, Oral, 0 mg, Once daily, 14 days

Protocol document: